Cite
HARVARD Citation
Tambaro, F. et al. (2020). Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD‐19 chimeric antigen receptor T‐cell therapy. Clinical case reports. 8 (9), pp. 1678-1681. [Online].